Showing results (501-510 of 556) with videos related to
Sort By:
Pageof 56
Molecular Pharmacology|September 22, 2000
Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin UJ A Hedrick, K Morse, L Shan, et al.Zhonghua Yi Xue Za Zhi|October 13, 2022
[Prognostic value of pulmonary hemodynamic parameters for predicting survival in acute coronary syndrome]R L Quan, D A Huang, L P Pang, et al.Cell Death & Disease|February 1, 2014
GLI2 induces genomic instability in human keratinocytes by inhibiting apoptosisE Pantazi, E Gemenetzidis, G Trigiante, et al.Cancer Research|September 15, 1995
Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progressionS Takahashi, A L Shan, S R Ritland, et al.Genetics and Molecular Research : GMR|February 25, 2016
PI3K, AKT, and P-AKT levels in thin endometriumA W Le, L L Shan, X Y Dai, et al.The Journal of Biological Chemistry|September 30, 2000
Identification of a novel neuromedin U receptor subtype expressed in the central nervous systemL Shan, X Qiao, J H Crona, et al.The American Journal of Pathology|January 6, 2001
Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancerQ Yang, I Mori, L Shan, et al.Nature Communications|November 18, 2010
Anisotropic structure of the order parameter in FeSe(0.45)Te(0.55) revealed by angle-resolved specific heatB Zeng, G Mu, H Q Luo, et al.Oncogene|July 16, 2013
GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporationL Shan, X Li, L Liu, et al.Journal of Medicinal Chemistry|September 27, 1996
Cycloalkylpyranones and cycloalkyldihydropyrones as HIV protease inhibitors: exploring the impact of ring size on structure-activity relationshipsK R Romines, J K Morris, W J Howe, et al.Pageof 56